Table 1
Clinical features of patients with chorea associated with the use of oral contraceptives in the last 23 years
| Reference | Patient age (years) | Time of use | Duration of chorea (weeks) | Clinical presentation/onset | Medical history | Comments |
|---|---|---|---|---|---|---|
| PET, Positron emission tomography; FDG, 18F-fluorodeoxyglucose. | ||||||
| Nausieda2 | 20 | 12 weeks | 1 | Hemichorea/ insidious | Congenital cardiopathy | |
| 17 | 2 weeks | 2 | Bilateral/ insidious | Sydenham̈‘s chorea | ||
| 18 | 8 weeks | 3 | Bilateral/ insidious | Sydenham̈‘s chorea | ||
| 21 | 2 weeks | 2 | Bilateral/ insidious | Congenital cardiopathy | ||
| 20 | 11 weeks | 2 | Hemichorea/ insidious | Purpura | Normal pregnancy | |
| Dove7 | 20 | 8 months | 8 | Hemichorea/ insidious | Rheumatic fever | 2 normal pregnancies |
| Greene8 | 16 | 2 months | 8 | Bilateral/ insidious | Sydenham’s chorea | Chorea gravidarum |
| Buge9 | 26 | 2 months | 6 | Hemichorea/ insidious | None | |
| 23 | 8 years | 2 | Hemichorea/ insidious | Normal pregnancy | ||
| Berger10 | 21 | 4 years | 4 | Hemichorea/ insidious | None | Normal pregnancy |
| Vela16 | 27 | Not specified | 16 | Hemichorea/ insidious | None | PET with FDG showed increased glucose metabolism in contralateral caudate nucleus |
| Present case | 19 | 2 years | 57 | Hemichorea/insidious | None | Presence of anti-basal ganglia antibodies |
